Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients

Annals of Surgical Oncology
Lars FischerChristoph M Seiler

Abstract

The objective of this study was to analyze factors leading to explantation of totally implanted access ports (TIAPs) and to assess its occurrence and clinical relevance. Of 438 patient consecutive patients with a port explantation, 385 were eligible for this retrospective cohort study. Reasons for explantation as well as demographic, clinical, and surgical characteristics were analyzed by univariate and multivariate models. The diagnoses leading to TIAP implantation were hematological malignancies in 142 patients (36.8%), breast cancer in 103 patients (26.8%), gastrointestinal cancer in 76 patients (19.8%), nonmalignant diseases in 46 patients (11.9%), and other malignant diseases in 18 patients (4.7%). The reasons for TIAP explantation were infection in 178 patients (46.2%), end of treatment in 129 patients (33.5%), thrombosis in 44 patients (11.4%), TIAP dysfunction in 22 patients (5.7%), and other reasons in 12 patients (3.2%). At the time of TIAP explantation, 115 patients (29.9%) were receiving chemotherapy, and 49 patients (12.7%) were considered immunocompromised. In case of TIAP explantation due to infection, the median length of TIAP in situ time was 303.3 days, whereas the cumulative 10-day and 30-day explantation rat...Continue Reading

References

Dec 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A ScalamognaC Ponticelli
Dec 17, 1997·Journal of Vascular and Interventional Radiology : JVIR·P C ShettyT H Burke
Jan 8, 1999·The New England Journal of Medicine·R O DarouicheG Mayhall
Jan 26, 1999·JAMA : the Journal of the American Medical Association·D L VeenstraS D Sullivan
Nov 20, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·UNKNOWN International Breast Cancer Study GroupAron Goldhirsch
Dec 15, 2005·Journal of Surgical Oncology·Christoph M SeilerHanns-Peter Knaebel
Aug 29, 2006·QJM : Monthly Journal of the Association of Physicians·S H AliyuA M L Lever
Sep 21, 2006·The Journal of Hospital Infection·P Gastmeier, C Geffers
Apr 20, 2007·The Cochrane Database of Systematic Reviews·A W WuJ L Tang
May 23, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·F NgT Meyer
Sep 1, 2001·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

❮ Previous
Next ❯

Citations

Jun 27, 2013·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·L Haeder, J Jähne
Feb 4, 2010·Cardiovascular and Interventional Radiology·Jan Peter GoltzRalph Kickuth
Dec 10, 2013·The Lancet Infectious Diseases·David LebeauxChristophe Beloin
Jan 21, 2017·American Journal of Clinical Oncology·Omidreza TabatabaieJennifer F Tseng
Feb 7, 2012·The Journal of Vascular Access·Evangelos PerdikakisDimitrios Tsetis
Mar 8, 2018·The Journal of Vascular Access·Fulvio PinelliMauro Pittiruti
Jul 24, 2014·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Jisue ShimSang Cheul Oh
Mar 29, 2011·Deutsches Ärzteblatt International·Ulf K TeichgräberHerbert A F Hofmann
Aug 15, 2020·Journal of Vascular and Interventional Radiology : JVIR·Philip SkummerMohammed Jawed
Nov 7, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Latif Volkan Tumay, Osman Serhat Guner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.